S&P 500   2,676.58 (+0.48%)
DOW   22,813.73 (+0.59%)
QQQ   197.28 (+0.41%)
AAPL   262.20 (-0.10%)
FB   169.85 (+2.60%)
MSFT   166.20 (+0.56%)
GOOGL   1,196.40 (+1.12%)
AMZN   2,023.96 (+1.32%)
NVDA   261.68 (-2.50%)
BABA   198.26 (+0.92%)
MU   47.13 (+1.64%)
TSLA   550.41 (+6.62%)
AMD   47.90 (+0.80%)
T   30.32 (+3.91%)
ACB   0.80 (+0.00%)
NFLX   375.14 (-1.27%)
BAC   22.48 (+5.10%)
GILD   74.40 (-4.28%)
DIS   102.32 (+2.75%)
S&P 500   2,676.58 (+0.48%)
DOW   22,813.73 (+0.59%)
QQQ   197.28 (+0.41%)
AAPL   262.20 (-0.10%)
FB   169.85 (+2.60%)
MSFT   166.20 (+0.56%)
GOOGL   1,196.40 (+1.12%)
AMZN   2,023.96 (+1.32%)
NVDA   261.68 (-2.50%)
BABA   198.26 (+0.92%)
MU   47.13 (+1.64%)
TSLA   550.41 (+6.62%)
AMD   47.90 (+0.80%)
T   30.32 (+3.91%)
ACB   0.80 (+0.00%)
NFLX   375.14 (-1.27%)
BAC   22.48 (+5.10%)
GILD   74.40 (-4.28%)
DIS   102.32 (+2.75%)
S&P 500   2,676.58 (+0.48%)
DOW   22,813.73 (+0.59%)
QQQ   197.28 (+0.41%)
AAPL   262.20 (-0.10%)
FB   169.85 (+2.60%)
MSFT   166.20 (+0.56%)
GOOGL   1,196.40 (+1.12%)
AMZN   2,023.96 (+1.32%)
NVDA   261.68 (-2.50%)
BABA   198.26 (+0.92%)
MU   47.13 (+1.64%)
TSLA   550.41 (+6.62%)
AMD   47.90 (+0.80%)
T   30.32 (+3.91%)
ACB   0.80 (+0.00%)
NFLX   375.14 (-1.27%)
BAC   22.48 (+5.10%)
GILD   74.40 (-4.28%)
DIS   102.32 (+2.75%)
S&P 500   2,676.58 (+0.48%)
DOW   22,813.73 (+0.59%)
QQQ   197.28 (+0.41%)
AAPL   262.20 (-0.10%)
FB   169.85 (+2.60%)
MSFT   166.20 (+0.56%)
GOOGL   1,196.40 (+1.12%)
AMZN   2,023.96 (+1.32%)
NVDA   261.68 (-2.50%)
BABA   198.26 (+0.92%)
MU   47.13 (+1.64%)
TSLA   550.41 (+6.62%)
AMD   47.90 (+0.80%)
T   30.32 (+3.91%)
ACB   0.80 (+0.00%)
NFLX   375.14 (-1.27%)
BAC   22.48 (+5.10%)
GILD   74.40 (-4.28%)
DIS   102.32 (+2.75%)
Log in

NYSE:APHAAphria Stock Price, Forecast & News

$3.05
+0.05 (+1.67 %)
(As of 04/7/2020 03:50 PM ET)
Add
Compare
Today's Range
$2.97
Now: $3.05
$3.25
50-Day Range
$2.13
MA: $3.16
$4.31
52-Week Range
$1.95
Now: $3.05
$10.11
Volume4.14 million shs
Average Volume5.03 million shs
Market Capitalization$815.11 million
P/E RatioN/A
Dividend YieldN/A
Beta2.26
Aphria Inc. produces and sells medical cannabis in Canada and internationally. The company offers sativa, indica, and hybrid medical marijuana products, as well as cannabis oils. It serves patients and health professionals. The company also sells its products online. Aphria Inc. is headquartered in Leamington, Canada.
Read More

Beat the Market (BTM) Rank

Analyst Opinion: 4.4Community Rank: 2.7Dividend Strength: 0.0Insider Behavior: 0.0Valuation: 1.9 5 -4 -3 -2 -1 -

Overall Beat the Market Rank

1.79 out of 5 stars


Industry, Sector and Symbol

Industry N/A
Sub-IndustryN/A
SectorMedical
CUSIPN/A
CIKN/A
WebN/A
PhoneN/A

Debt

Price-To-Earnings

Sales & Book Value

Annual Sales$179.29 million

Profitability

Miscellaneous

Employees300
Market Cap$815.11 million
Next Earnings Date4/20/2020 (Estimated)
OptionableNot Optionable

Receive APHA News and Ratings via Email

Sign-up to receive the latest news and ratings for APHA and its competitors with MarketBeat's FREE daily newsletter.


Aphria (NYSE:APHA) Frequently Asked Questions

How has Aphria's stock been impacted by COVID-19 (Coronavirus)?

Aphria's stock was trading at $2.70 on March 11th, 2020 when Coronavirus (COVID-19) reached pandemic status according to the World Health Organization. Since then, APHA stock has increased by 13.0% and is now trading at $3.05. View which stocks have been mosted impacted by Coronavirus.

Do Wall Street analysts recommend investors buy shares of Aphria?

8 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Aphria in the last year. There are currently 2 hold ratings and 6 buy ratings for the stock, resulting in a consensus recommendation of "Buy." View analyst ratings for Aphria.

When is Aphria's next earnings date?

Aphria is scheduled to release its next quarterly earnings announcement on Monday, April 20th 2020. View our earnings forecast for Aphria.

How were Aphria's earnings last quarter?

Aphria Inc (NYSE:APHA) released its quarterly earnings results on Tuesday, January, 14th. The company reported ($0.02) earnings per share (EPS) for the quarter, hitting the consensus estimate of ($0.02). The company earned $91.38 million during the quarter, compared to analyst estimates of $100.88 million. View Aphria's earnings history.

What guidance has Aphria issued on next quarter's earnings?

Aphria updated its FY 2020 Pre-Market earnings guidance on Tuesday, January, 14th. The company provided earnings per share (EPS) guidance of for the period. The company issued revenue guidance of $575-625 million.

What price target have analysts set for APHA?

8 equities research analysts have issued 12-month price targets for Aphria's shares. Their forecasts range from $4.50 to $22.75. On average, they expect Aphria's stock price to reach $10.55 in the next twelve months. This suggests a possible upside of 245.9% from the stock's current price. View analysts' price targets for Aphria.

Has Aphria been receiving favorable news coverage?

News headlines about APHA stock have trended very negative on Tuesday, according to InfoTrie. The research group rates the sentiment of press coverage by monitoring more than six thousand blog and news sources in real time. The firm ranks coverage of companies on a scale of negative five to positive five, with scores closest to five being the most favorable. Aphria earned a news impact score of -3.3 on InfoTrie's scale. They also gave headlines about the company a news buzz of 0.0 out of 10, indicating that recent press coverage is extremely unlikely to have an effect on the company's share price in the next several days. View the latest news aboutAphria.

Are investors shorting Aphria?

Aphria saw a increase in short interest during the month of March. As of March 13th, there was short interest totaling 36,620,100 shares, an increase of 9.7% from the February 27th total of 33,390,000 shares. Based on an average daily volume of 5,870,000 shares, the days-to-cover ratio is currently 6.2 days. Currently, 14.1% of the shares of the company are sold short. View Aphria's Current Options Chain.

Who are some of Aphria's key competitors?

What other stocks do shareholders of Aphria own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Aphria investors own include Aurora Cannabis (ACB), Canopy Growth (CGC), Cronos Group (CRON), Tilray (TLRY), NVIDIA (NVDA), OrganiGram (OGI), Alibaba Group (BABA), Charlotte's Web (CWBHF), HEXO (HEXO) and Advanced Micro Devices (AMD).

Who are Aphria's key executives?

Aphria's management team includes the following people:
  • Mr. Carl A. Merton, Chief Financial Officer
  • Ms. Megan McCrae, Director of Marketing
  • Mr. Irwin D. Simon, Interim CEO & Chairman
  • Mr. Jakob Ripshtein, Pres
  • Mr. Gary Leong, Chief Science Officer (Age 54)

What is Aphria's stock symbol?

Aphria trades on the New York Stock Exchange (NYSE) under the ticker symbol "APHA."

How do I buy shares of Aphria?

Shares of APHA can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

What is Aphria's stock price today?

One share of APHA stock can currently be purchased for approximately $3.05.

How big of a company is Aphria?

Aphria has a market capitalization of $815.11 million and generates $179.29 million in revenue each year. Aphria employs 300 workers across the globe. View additional information about Aphria.

This page was last updated on 4/7/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel